Endoplasmic reticulum stress and Nrf2 repression in circulating cells of type 2 diabetic patients without the recommended glycemic goals by C.  Mozzini et al.
apoptosis [3,4]. Nevertheless, conditions of glucose depri-
vation can also cause ER stress, with proven activation of 
the UPR and the ER apoptosis [5].
Briefly, in all conditions perturbing the ER, three ER 
trans-membrane sensors are activated to initiate adaptive 
responses [6,7]. These sensors include protein kinase-
like ER kinase (PERK), inositol-requiring kinase 1, and 
the activating transcription factor 6. All three sensors are 
maintained in an inactive state through the interaction of 
their N-terminus with the glucose-regulated protein 
78 kDa (GRP78, also called BiP). When unfolded pro-
teins accumulate in the ER, BiP releases these sensors to 
allow their oligomerization and thereby initiates the UPR 
[1]. Once the UPR fails to control the levels of the unfolded 
and misfolded proteins in the ER, the ER-initiated 
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Abstract
Endoplasmic reticulum (ER) stress plays a role in the pathogenesis of type 2 diabetes mellitus (T2DM), with activation of the unfolded 
protein response (UPR) and ER apoptosis in b-cells. The aim of the study is investigating the role of the prolonged glycemic, inflamma-
tory, and oxidative impairment as possible UPR and ER apoptosis inductors in triggering the ER stress response and the protective nuclear 
erythroid-related factor 2 (Nrf2)/antioxidant-related element (ARE) activation in peripheral blood mononuclear cells (PBMC) of T2DM 
patients without glycemic target.
Oxidative stress markers (oxidation product of phospholipid 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine [oxPAPC], and 
malondialdehyde [MDA]), the UPR and ER apoptosis, the activation of the pro-inflammatory nuclear factor-kappa B (NF-kB) with its 
inhibitory protein inhibitor-kBa, and the expression of the protective Nrf2 and heme oxygenase-1 (HO-1) were evaluated in PBMC of 
15 T2DM patients and 15 healthy controls (C).
OxPAPC concentrations (in PBMC and plasma), MDA levels (in plasma), the expressions of the glucose-regulated protein 78 kDa 
(or BiP) as representative of UPR, and of the CCAAT/enhancer-binding protein homologous protein as representative of ER apoptosis 
were significantly higher (p  0.01) in T2DM with respect to C. IkBa expression was significantly lower (p  0.01) in T2DM as well as 
Nrf2 and HO-1.
In vitro experiments demonstrated that hyperglycemic conditions, if prolonged, were NF-kB inductors, without a corresponding 
Nrf2/ARE response.
In PBMC of T2DM without glycemic target achievement, there is an activation of the UPR and of the ER apoptosis, which may be related 
to the chronic exposure to hyperglycemia, to the augmented inflammation, and to the augmented oxidative stress, without a corresponding 
Nrf2/ARE defense activation.
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requiring kinase 1; HOMA, homeostatic model of insulin resistance; MAGE, mean amplitude of glycemic excursion; MDA, malondialdehyde; 
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Background
A growing body of evidence has suggested in the last 
years that the endoplasmic reticulum (ER) stress is 
involved in the pathogenesis of type 2 diabetes mellitus 
(T2DM), contributing to loss of pancreatic b-cells and 
resistance to insulin [1].
If the most convincing emphasis for the role of ER 
stress in b-cells failure was initially found by studying rare 
genetic disorders [1,2], evidence for animal and human 
pancreatic islets ER stress has been proven in conditions 
where b-cells were exposed to high glucose concentra-
tions, which has been seen to overwhelm the ER folding 
capacity, causing an imbalance in homeostasis and leading 
to the unfolded protein response (UPR) and to the ER 
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apoptotic signaling is induced, with the activation of the 
death factor CCAAT/enhancer-binding protein homolo-
gous protein (CHOP) [1,6].
Oxidative stress plays a key role both in the initiation 
and in the progression of T2DM, which is accompanied 
by increased production of the reactive oxygen species 
(ROS), contributing to the insulin resistance and to the 
activation of pro-inflammatory signaling pathways, mainly 
regulated by the pro-inflammatory nuclear factor-kappa B 
(NF-kB) [8,9].
Normally held in the cytoplasm in complex with the 
inhibitor-kBa (IkBa), canonical activation of NF-kB 
involves phosphorylation of IkBa and its proteasome deg-
radation when inflammation occurs [10].
One of the most important cellular defense mechanisms 
against oxidative stress is regulated by the nuclear eryth-
roid-related factor 2 (Nrf2)/antioxidant-related element 
(ARE), a PERK-dependent master transcriptional activa-
tor, which regulates many of the antioxidant enzymes 
[11–13].
The primary aim of this study is the evaluation of the 
UPR and the ER-initiated apoptotic signaling in circulat-
ing cells (peripheral blood mononuclear cells, PBMC) of 
T2DM patients without glycemic target achievement. In 
fact, if many studies have been conducted on pancreatic 
b-cells [3,4] consistent with our previous results in patients 
with stable coronary artery disease (CAD) [14], few but 
consistent data [15] suggest that the circulating cells are 
also vulnerable to ER stress in T2DM patients. It is known 
that they are likely susceptible to ER-stress-induced alter-
ations in inflammatory/oxidative environment, as it occurs 
in atherosclerosis and diabetes [14,15], indicating that the 
circulating surrounding may also be somehow altered.
The second aim of this study is investigating the short 
and prolonged effect of glucose on UPR, on ER-initiated 
apoptotic signaling, on activation of pro-inflammatory 
signaling pathways, and on the protective Nrf2/ARE acti-
vation in cultured monocytoid THP-1 cells.
Methods
Study population
The study was approved by the hospital ethics committee 
in accordance with the ethical standard of the Declaration 
of Helsinki, and informed consent was obtained from all 
the patients before their enrollment.
The major requirements for the enrollment in all the 
groups were absence of infectious or acute/chronic 
inflammatory diseases, known malignancy, absence of 
acute/chronic renal failure, hepatic failure, ischemic 
heart disease, current smoking, hypertension, obesity, 
and pregnancy.
Two groups of subjects were studied: 15 patients with 
T2DM and 15 control healthy subjects (C). All the T2DM 
patients had T2DM diagnosed  6 months before the 
study entry, poorly controlled, and without regular treat-
ment for diabetes at the time of the blood sample collec-
tion, recruited from the Department of Internal Medicine, 
University Hospital of Verona, Italy. All the C subjects 
were age-matched nurses or physicians working in the 
same department, who had no cardiovascular risk factors 
(hypertension, cigaret smoking, diabetes mellitus, hyper-
cholesterolemia, obesity, and family history of premature 
cardiovascular disease), no continuative drug therapy, and 
no history of any acute or chronic disease.
Following a 12-hour overnight fast, all subjects were 
subjected to venous blood sampling.
Blood samples and PBMC isolation
Blood was collected from each subject and drawn into 
pyrogen-free blood collection tubes. Multiple aliquots of 
serum or plasma were placed into sterile 1-ml screw-
capped polypropylene vials, containing phenolic antioxi-
dant 2,6-di-tert-butyl-4-methylphenol (10 mM) (SIGMA, 
Milan, Italy) to inhibit lipid peroxidation, and stored at 
280°C. Samples were kept frozen for no longer than 9 
months with an average of 5 months. The samples were 
frozen and thawed only once. PBMC were isolated as pre-
viously described [16]. Total cholesterol, high-density 
lipoprotein (HDL) cholesterol, low-density lipoprotein 
(LDL) cholesterol, triglycerides, glucose, insulin, and 
glycated hemoglobin (HbA1%) levels were measured with 
standard methods.
C-reactive protein (CRP) was measured by a commer-
cially available high-sensitivity turbidimetric method 
(Synhron-PCR, Beckman Coulter, Brea CA, USA).
Evaluation of phospholipid oxPAPC in plasma and  
in PBMC from C subjects and T2DM patients
1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcho-
line (oxPAPC) in plasma and in PBMC of C subjects and 
T2DM patients were measured on an Agilent mass spec-
trometer equipped with an electrospray source (Agilent 
Technologies, Milan, Italy) as previously described [17]. 
The following different oxPAPCs were taken into consider-
ation: 1-palmitoyl-2-(5,6-epoxyisoprostane E2)-sn-glycero- 
3-phosphorylcholine (PEIPC); 1-palmitoyl-2-(5-oxovaleroyl)- 
sn-glycero-3-phosphorylcholine (POVPC); and 1-palmitoyl- 
2-glutaroyl-sn-glycero-3-phosphorylcholine (PGPC). 
Flow injection experiments were performed using a high-
performance liquid chromatography (HPLC) system 
(HP1100; Agilent Technologies, Milan, Italy). Quantifica-
tion of the peak areas was performed by single ion moni-
toring in the elution time range of 10–20 min using 
appropriate software. Authentic PAPC, POVPC, and 
PGPC were obtained from Avanti Polar Lipids, Inc. 
(Delfzijl, The Netherlands). PEIPC was prepared and ana-
lyzed in our laboratory as previously described [18].
MDA detection
Malondialdehyde (MDA) detection in plasma and cul-
ture medium was achieved by HPLC with fluorescence 
detection [19].
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Quantitative real-time PCR
Quantitative real-time PCR analysis was performed as 
previously described [16]. Total RNA was extracted from 
PBMC with an RNeasy Mini Kit (Qiagen, Milan, Italy) 
and was reverse-transcribed using IScript cDNA Synthe-
sis Kit (Bio-Rad, Hercules, CA, USA). The relative 
expression levels of mRNA encoding GRP78/BiP, PERK, 
CHOP, IkBa, Nrf2, and HO-1 subunits were measured 
by iCycler (Bio-Rad, Hercules, CA, USA), using IQSYBR 
Green PCR SuperMix (Bio-Rad, Hercules, CA, USA) and 
300 nM of each primer pair. Primers were designed using 
Beacon Design 4.0 software (PREMIER Biosoft Interna-
tional, Palo Alto, CA, USA) and synthesized using MWG 
Biotech AG (Ebersberg, Germany) [16]. Normalized gene 
expression levels were given as the ratio between the 
mean value for the target gene and that for the b-actin in 
each sample.
Western blot analysis
Western blot analysis was performed as previously 
described [16]. In particular, PERK, GRP78/BiP, CHOP, 
IkBa, Nrf2, and HO-1 were immunoprecipitated from 
1 mg of each PBMC protein lysate or nuclear lysate with 
mouse monoclonal antibodies, and anti-b-actin (Santa 
Cruz Biotechnology, Heidelberg, Germany). Immune 
complexes were captured with protein A/G-Sepharose 
beads (Pierce, Rockford, IL, USA) for 2 h, and the beads 
were washed four times with 100 mM of NaCl. To ensure 
the specificity of protein antibody interaction, lysates were 
incubated with beads in the absence of antibody as well 
as with an irrelevant immunoglobulin isotype control 
(Caltag, Little Balmer, UK). PERK, GRP78/BiP, CHOP, 
IkBa, Nrf2, and HO-1 were detected by probing immu-
noprecipitates with rabbit polyclonal antibodies (Santa 
Cruz Biotechnology, Heidelberg, Germany), followed by 
goat anti-rabbit horseradish peroxidase-conjugated sec-
ondary antibody (Bio-Rad, Hercules, CA, USA). Reactive 
antigens were visualized with SuperSignal chemilumines-
cence substrate (Pierce, Rockford, IL, USA) and quanti-
fied by densitometry analysis with ChemiDoc XRS 
(Bio-Rad). Protein expression data were quantified with 
Quantity One Software (Bio-Rad, Hercules, CA, USA).
In vitro analysis
THP-1 monocytoid cells were incubated for 2 h and over-
night (ON) with different concentrations of glucose: 
10 mM and 25 mM. At the times indicated, ROS, MDA, 
PGPC, and the expression levels of PERK, CHOP, IkBa, 
Nrf2, and HO-1 were evaluated with or without the pres-
ence of the inhibitor of nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase diphenyliodonium (DPI; 
50 mM), superoxide dismutase (SOD, 150 U/ml), and 
catalase (CAT, 200 U/ml). Intracellular ROS production 
was quantified through the oxidation of 2,7-dichlorofluo-
rescin diacetate as previously described [20]. To examine 
the intracellular esterase activity in basal and glucose-
stimulated THP-1 cells, we used 5,6-carboxy-2,7-dichlo-
rofluorescein diacetate (CF-DA); its hydrolysis produced 
a fluorescence product [21].
To study the relationship between the UPR and the 
ER-initiated apoptotic signaling with the Nrf2/ARE 
response and the cellular content of oxPAPC, THP-1 
monocytoid cells were also incubated with crescent con-
centrations of PGPC (in a range from 0 to 1.6 ng/mg 
PAPC) with or without the presence of the inhibitor of 
NADPH oxidase DPI (50 mM) for 6 h; ROS, GRP78/
BiP, CHOP, and Nrf2/ARE gene expression levels were 
quantified [14].
Apoptosis assay
Apoptosis was determined by staining cells with annexin 
V-fluorescein isothiocyanate (FITC; Ex/Em  488/ 
519 nm; Invitrogen Corporation, Camarillo, USA).
Statistical analysis
Data are presented as mean  SD. Statistical analysis was 
performed by two-tailed unpaired Student’s t-test and by 
one- or two-way analysis of variance for repeated measures 
followed by post-hoc Tukey’s test for multiple comparisons 
using the “SYSTAT” program and statistical software 
manual (SYSTAT Inc., Evanston, Illinois) for Macintosh. 
Statistical significance was inferred at p values  0.05.
Results
Baseline characteristics of the subjects
Baseline clinical characteristics and laboratory data of 
T2DM patients and C subjects are described in Table I.
T2DM patients did not present target fasting plasma 
glucose or HbA1% concentrations, according to the Amer-
ican Diabetes Association (ADA) 2014 Guidelines [22]. 
There was no difference in total and LDL cholesterol levels 
between the two groups. HDL level was significantly lower 
in T2DM than in C subjects. Plasma levels of high-sensi-
tivity (hs)-CRP and MDA were significantly much higher 
in T2DM patients than in healthy C subjects (p  0.01).
UPR, ER apoptosis, NF-kB activation, and Nrf2/ARE 
expression in PBMC of T2DM patients and healthy  
C subjects
Figure 1a and b shows the mRNA and protein expression 
of GRP78/BiP, CHOP, Nrf2, HO-1, and IkBa in PBMC 
of all T2DM patients and healthy C subjects considered 
in this study. GRP78/BiP and CHOP expression was sig-
nificantly higher in T2DM patients than in healthy C sub-
jects (p  0.01). Furthermore in T2DM the mRNA and 
protein expression of Nrf2, HO-1, and IkBa were signifi-
cantly lower in T2DM patients than in healthy C subjects 
(p  0.01).
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OxPAPC concentrations in plasma and PBMC of T2DM 
patients and healthy C subjects
Figure 2a and b shows the concentrations of oxPAPC in 
plasma and PBMC of all T2DM patients and healthy C 
subjects considered in this study.
The plasma and PBMC concentrations of oxPAPC 
measured in this study (PEIPC, POVPC, and PGPC) were 
significantly higher in T2DM patients than in healthy C 
subjects (p  0.01).
In vitro analysis: ROS, MDA, and PGPC generation and 
PERK, CHOP, IkBa, Nrf2, and HO-1 expression in 
THP-1 cells incubated with different concentrations  
of glucose for 2 h and ON
There was a dose-dependent effect of glucose concentra-
tion on ROS generation in THP-1 cells at different times 
(p  0.01), which was inhibited by DPI (p  0.01) and by 
SOD CAT (Figure 3a and b). The difference was not 
linked to glucose-stimulated variation of esterase activity 
since the fluorescence produced by CF-DA was not sig-
nificantly different in basal and glucose-stimulated THP-1 
cells (data not shown).
Glucose-induced ROS generation was associated to a 
dose- and time-dependent rise of MDA in the culture 
medium (p  0.01) and of PGPC in THP-1 cell extracts, 
which was also inhibited by DPI (p  0.01) (Figure 3c 
and d).
Figure 4a and b shows the mRNA and protein expression 
of PERK, CHOP, IkBa, Nrf2, and HO-1 after 2 h and ON 
incubation with 10 and 25 mM of glucose. The expression 
of PERK, chosen as representative of UPR and as Nrf2 
transcriptional activator, was significantly higher (p  0.01) 
at glucose concentration of 25 mM at 2 h, without increase 
at glucose concentration of 25 mM ON.
The expression of CHOP, as representative of ER apop-
tosis, was significantly higher (p  0.01) only at glucose 
concentrations of 25 mM ON. Induction of apoptosis has 
been demonstrated with a significant increase of Annexin 
V cells at glucose concentration of 25 mM ON. The 
expression of IkBa was significantly lower (p  0.01) both 
at glucose concentrations of 10 and 25 mM at 2 h, and at 
glucose concentration of 25 mM ON. The expression of 
Nrf2 was significantly higher (p  0.01) at glucose con-
centrations of 25 mM at 2 h, with a lack of increase at 
glucose concentration of 25 mM ON. The expression of 
HO-1 was even significantly lower (p  0.01) at glucose 
concentrations of 25 mM ON with respect to all the other 
conditions.
Table I. Clinical characteristics and values of metabolic, 
inflammatory, and oxidative parameters in T2DM patients and 
healthy C subjects.
C (n  15)
T2DM 
(n  15) p
Age (years) 62  5 59  5 ns
Male/Female 8/7 8/7 ns
BMI (Kg/m2) 24  1 28  1  0.05
SBP (mmHg) 129  5 130  5 ns
DBP (mmHg) 82  5 79  3 ns
Heart rate (bpm) 67  5 68  5 ns
Total cholesterol (mg/dL) 163  5 177  9 ns
LDL cholesterol (mg/dL) 89  8 98  7 ns
HDL cholesterol (mg/dL) 52  5 39  4  0.05
Triglycerides (mg/dL) 126  16 144  18 ns
FPG (mmol/L) 5.4  0.1 15.8  1  0.01
HbA1% 5.5  0.5 12  3  0.01
HOMA nd 5  0.5 nd
Insulin (mU/L) nd 7.1 nd
hs CRP (mg/L) 0.6  0.06 5  0.02  0.01
MDA (mmol/L) 0.8  0.05 3.5  0.09  0.01
 C, healthy control subjects; T2DM, type 2 diabetes mellitus patients; BMI, 
body mass index; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; FPG, fasting plasma glucose; HbA1%, glycated hemoglobin; 
HOMA, homeostasis model of insulin resistance (fasting blood glucose  
fasting insulin)/22.5; hs CRP, high-sensitivity C-reactive protein; MDA, 
malondialdehyde; ns, not significantly different; nd, not determined; data are 
expressed as mean  SD.
Figure 1. GRP78/BiP, CHOP, Nrf2, HO-1, and IkBa mRNA and 
protein expression in PBMC mRNA of GRP78/BiP, CHOP, Nrf2, 
HO-1, and IkBa were analyzed by quantitative real-time PCR (a). 
Normalized gene expression levels were given as the ratio between 
the mean value for the target gene and that for the b-actin in each 
sample. Representative Western blot analysis for the indicated 
proteins and the average quantification obtained by densitometric 
analysis of all the samples derived from healthy control subjects (C) 
and from T2DM patients (b). Data on Western blot analysis 
are expressed as the density ratio of target protein (1) to control 
(b-actin) (2) in arbitrary units. Data represent the mean  SD of 
measurements performed in triplicate in all T2DM patients and 
healthy C subjects. *p  0.01 versus C.
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In vitro effects of PGPC on ROS generation and GRP78/
BiP, CHOP, and Nrf2/ARE gene expression are indicated 
in Figure 5.
THP-1 cells incubated with increasing amounts of 
PGPC (in the range from 0 to 1.6 ng/mg PAPC) showed 
a dose-dependent increase in ROS generation (p  0.01) 
(Figure 5a and b). The generation of ROS in THP-1 
cells was greatly reduced in the presence of the 
NADPH oxidase inhibitor DPI (p  0.01) and by 
SOD CAT.
We also found that PGPC dose-dependently increased 
the mRNA and protein expression of GRP78/BiP and 
CHOP (p  0.01), which was reduced by DPI (p  0.01) 
(Figure 5c and d). Otherwise, the behavior of Nrf2/ARE 
gene expression induced by PGPC was different depend-
ing on its concentration. At low concentrations, PGPC 
evoked a dose-dependent rise in Nrf2 and HO-1 
(p  0.01), whereas at higher concentrations, it reduced 
Nrf2/ARE gene expression (p  0.01) (Figure 5c and d). 
As shown in Figure 5c and d, DPI reversed the reduction 
in Nrf2/ARE gene expression induced by the highest 
concentrations of PGPC (p  0.01).
Discussion
In this study we have investigated the UPR and the ER-
initiated apoptotic signaling in circulating cells of T2DM 
patients without the recommended glycemic goals and the 
role of the prolonged glycemic, inflammatory, and oxida-
tive stress as possible UPR and ER apoptosis inductors in 
triggering and orchestrating the ER stress response and the 
Nrf2/ARE pathway activation.
We have first demonstrated that the expression of 
GRP78/BiP as representative of UPR and of CHOP as 
representative of ER-initiated apoptotic signaling was sig-
nificantly higher in PBMC of T2DM patients than in 
healthy C subjects.
Animal and human studies have confirmed the activa-
tion of ER stress markers under condition of hypergly-
cemia. In fact, mouse pancreatic islets pretreated with 
different glucose concentrations induced an increase 
of ER stress markers expression with a correspondent 
inadequate insulin secretion at the highest glucose con-
centrations [3].
Moreover, in human studies, ER stress and UPR activa-
tion markers were increased in b-cells from pancreatic 
sections of T2DM patients compared with non-diabetic 
pancreatic tissue [23].
However, there are only few data about the ER stress 
involvement in circulating cells of T2DM patients and 
their vulnerability to hyperglycemia-induced ER stress 
and dysfunction [15]. In this study authors demonstrated 
that monocytes derived from patients with T2DM were 
more susceptible to apoptosis than those derived from 
healthy volunteers and that they showed an elevated 
expression of the markers of ER stress. However, there 
was a lack of knowledge about why and by what mecha-
nisms circulating cells were vulnerable in T2DM. Our 
study has tried to better investigate this point: the fact that 
the UPR and the ER apoptosis are activated in PBMC of 
T2DM patients indicates that the circulating environment 
may also be somehow altered in T2DM patients, with 
analogies with our results in CAD patients [14]. Of course, 
in the case of T2DM the “primum movens” may be hyper-
glycemia, a situation that is supposed to start a series of 
reactions leading to an increased production of ROS via 
activation of NADPH oxidase [24,25]. As a matter of fact, 
in our in vitro studies we demonstrated that glucose dose-
dependently increased ROS generation at different times 
and that the increase was inhibited by DPI, a specific 
inhibitor of NADPH oxidase. The glucose-induced ROS 
generation was associated, after prolonged incubation 
with high concentration of glucose, with a significant 
increase of CHOP. Otherwise, PERK expression was 
higher at 2nd hour of incubation with 25 mM of glucose. 
The fact that DPI inhibited the expression of PERK and 
CHOP, respectively, after 2 h and after overnight incuba-
tion indicates that ROS may play a major role in UPR and 
in ER-initiated apoptotic signaling.
The results of this study also show that MDA concen-
tration was higher in T2DM than in healthy C. Our results 
concerning increased MDA levels in T2DM are consistent 
Figure 2. OxPAPC concentrations in serum and in PBMC of all 
T2DM patients and healthy C subjects. Serum concentrations of 
oxPAPC, PEIPC, POVPC, and PGPC in healthy subjects (C) and in 
T2DM patients (a). OxPAPC (PEIPC, POVPC, and PGPC) 
concentrations in PBMC of healthy C subjects and of T2DM patients 
(b). Data represent the mean  SD of measurements performed in 
triplicate in all T2DM patients and healthy C subjects. *p  0.01 
versus C.
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with previous data [26,27], also in patients with newly 
diagnosed T2DM [28]. Increased production of ROS in 
T2DM patients may therefore affect oxidation of fatty 
acids since MDA is a collection of end-products of various 
types of oxidized fatty acids, and it is used to estimate 
lipid peroxidation in vivo. These oxidized fatty acids may 
derive from oxidation of cellular membrane phospholip-
ids, a primary target of superoxide generated by NADPH-
oxidase [29]. The fact that in this study plasma and PBMC 
concentrations of oxPAPC were significantly higher in 
T2DM patients than in healthy C subjects agrees with this 
hypothesis. This view is also supported by the results we 
obtained in in vitro studies where incubation with high 
concentration of glucose induced an increase of MDA and 
oxPAPC that was inhibited by DPI, an inhibitor of NADPH 
oxidase. In turn the results of this study also show that 
oxPAPC further potentiate the generation of ROS via 
NADPH oxidase indicating that these compounds may 
contribute to generating ER stress.
This study was also aimed to examine the role of 
inflammation, NF-kB, and Nrf2 signaling in T2DM. 
NF-kB activation in the T2DM patients of this study 
(resulting in decreasing expression of total IkBa) confirms 
the growing evidence that considers the ER as a crucial 
site where metabolic and inflammatory pathways converge 
[30]. ER stress and inflammation have been shown to be 
interconnected through various mechanisms and in par-
ticular through the activation of NF-kB [31], a master 
transcription factor with numerous functions including the 
regulation of the inflammatory response, with proven 
involvement in T2DM [32]. It has been proposed that 
NF-kB activation during ER stress depends on UPR- 
induced IkBa reduction [33]. Of course, activation of 
NF-kB may also be a consequence of oxidative stress as 
previously demonstrated in other cells [34]. These conclu-
sions are in line with the results we obtained in vitro. The 
glucose- and ROS-induced ER stress in THP-1 cells was 
associated with a reduction in IkBa and at any time at any 
concentration of glucose.
Despite the presence of ER stress and the augmented 
levels of oxidative stress and inflammation, we observed 
an inadequate response of Nrf2/ARE response in PBMC 
of T2DM patients. Our results are in agreement with a 
series of studies where the same inadequacy was reported 
in other chronic pathologies such as chronic kidney failure 
[35], chronic obstructive pulmonary disease [36], and 
chronic CAD, as we have recently demonstrated [14]. Also 
in vitro experiments confirmed that in hyperglycemic con-
ditions, if prolonged (glucose concentration of 25 mM 
ON), there was no Nrf2/ARE response, as it conversely 
occurred in acute extreme conditions (glucose concentra-
tion of 25 mM at 2 h).
So it is likely that it is an excess of oxidative or meta-
bolic stress that orchestrates the switch from the protec-
tive UPR and Nrf2/ARE gene expression to ER-initiated 
apoptotic signaling and this could explain the similar 
results in different pathologies, as we have already sup-
posed in previous studies [14,17]. Similar impairments in 
Figure 3. In vitro analysis: ROS, MDA, and PGPC generation in THP-1 cells incubated with different concentrations of glucose for 2 h and 
ON. Effect of glucose concentration on ROS generation in THP-1 cells at 2 h and ON,  or 2 DPI (50 mM)  SOD (150 U/ml)  CAT 
(200 U/ml) (a and b). Effect of glucose concentration on MDA and on PGPC in THP-1 cells at 2 h and ON  or 2 DPI (50 mM) (c and d). 
Data represent the mean  SD of measurements performed in triplicate in six different occasions. *p  0.01 versus basal, †p  0.01 versus 
glucose 10 mM, ‡p  0.01 versus  DPI. MFI  mean fluorescence intensity.
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Nrf2/ARE were observed in the endothelial cells exposed 
to high glucose in the retina from donors with diabetic 
retinopathy [37].
We are conscious that this study has several limita-
tions: first of all the not wide sample of patients (that 
nevertheless it is principally due to the precise catego-
rization of the patients enrolled, as explained in exclu-
sion criteria section). Second, it should be important to 
evaluate the mean amplitude of glycemic excursions as 
estimated by continuous glucose monitoring systems, 
which remains certainly the most comprehensive index 
for assessing the intraday glycemic variability. In fact, it 
has been demonstrated that glucose fluctuations during 
postprandial periods and, more generally, during glu-
cose swings, exhibited a more specific triggering effect 
on oxidative stress than chronic sustained hyperglyce-
mia [38,39].
Conclusions
In conclusion, the present study has demonstrated that in 
PBMC of T2DM patients without glycemic target achieve-
ment, there is activation of the UPR and of the ER apop-
tosis, which may be related to the chronic exposure to 
hyperglycemia, to the augmented inflammation, and to the 
Figure 4. In vitro analysis: PERK, CHOP, IkBa, Nrf2, and HO-1 expression and annexin V-FITC assay in THP-1 cells incubated with 
different concentrations of glucose for 2 h and ON. mRNA and protein expression of PERK, CHOP, IkBa, Nrf2, and HO-1 after 2-h 
incubation with 10 and 25 mM of glucose (a and b). mRNA and protein expression of PERK, CHOP, IkBa, Nrf2, and HO-1 after ON 
incubation with 10 and 25 mM of glucose (c and d). The percentage of annexin V-FITC-positive cells after 2-h incubation with 10 and 
25 mM of glucose (e) and after ON incubation with 10 and 25 mM of glucose (f). Representative Western blot analysis for the indicated 
proteins and the average quantification was obtained by densitometric analysis of all the samples. Data on Western blot analysis are expressed 
as the density ratio of target protein (1) to control (b-actin) (2) in arbitrary units. Data represent the mean  SD of measurements performed 
in triplicate in six different occasions. *p  0.01 versus basal, †p  0.01 versus glucose (10 mM)-DPI, ‡p  0.01 versus glucose (10 mM)-
DPI, §p  0.01 versus glucose (25 mM)-DPI.
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8 C. Mozzini et al. 
augmented oxidative stress, without a corresponding Nrf2/
ARE defense activation, allowing new insight into the cir-
culating environment of T2DM patients.
Declaration of interest
The authors report no conflicts of interest. The authors 
alone are responsible for the content and writing of the 
paper. 
References
[1] Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic 
reticulum stress in diabetes mellitus. Endocr Rev 2008;29: 
42–61.
[2] Papa FR. Endoplasmic reticulum stress, pancreatic b-cells 
degeneration, and diabetes. Cold Spring Harb Perspect Med 
2012;2:a007666.
[3] Lipson KL, Fonseca SG, Ishigaki S, Nguyen LX, Foss E, 
Bortell R, et al. Regulation of insulin biosynthesis in pancre-
atic beta cells by an endoplasmic reticulum-resident protein 
kinase IRE1. Cell Metab 2006;4:245–254.
[4] Elouil H, Bansellam M, Guiot Y, Vander Mierde D, Pascal SM, 
Schuit FC, Jonas JC. Acute nutrient regulation of unfolded 
protein response and integrated stress response in cultured rat 
pancreatic islets. Diabetologia 2007;50:1442–1452.
[5] De la Cadena SG, Hernandez-Fonseca K, Camacho-Arroyo I, 
Massieu L. Glucose deprivation induces reticulum stress 
by the PERK pathway and caspase-7 and calpain-mediated 
caspase-12 activation. Apoptosis 2014;19:414–427.
[6] Kaufman RJ. Orchestrating the unfolded protein response in 
health and disease. J Clin Invest 2002;110:1389–1398.
[7] Ron D, Walter P. Signal integration in the endoplasmic reticu-
lum unfolded protein response. Nat Rev Mol Cell Biol 2007; 
8:519–529.
[8] Styskal JL, Van Remmen H, Richardson A, Salmon AB. Oxi-
dative stress and diabetes: what can we learn about insulin 
resistance from antioxidant mutant mouse models? Free Radic 
Biol Med 2012;52:46–58.
[9] Rains JL, Jain SK. Oxidative stress, insulin signaling, and 
diabetes. Free Radic Biol Med 2011;50:567–575.
[10] Hayden MS, Ghosh S. Shared principles in NF-kappaB sign-
aling. Cell 2008;132:344–362.
[11] Gorlach A, Klappa P, Kietzmann T. The endoplasmic 
reticulum: folding, calcium homeostasis, signalling, and redox 
control. Antioxid Redox Signal 2006;8:1391–1418.
[12] Cullinan SB, Diehl JA. PERK-dependent activation of Nrf2 
contributes to redox homeostasis and cell survival following 
endoplasmic reticulum stress. J Biol Chem 2004;279: 
20108–20117.
[13] Singh S, Vrishni S, Singh BK, Rahman I, Kakkar P. Nrf2/ARE 
stress response mechanism: a control point in oxidative stress 
mediated dysfunction and chronic inflammatory disease. Free 
Radic Res 2010;44:1267–1288.
[14] Mozzini C, Fratta Pasini A, Garbin U, Stranieri C, Pasini A, 
Vallerio P, Cominacini L. Increased endoplasmic reticulum 
stress and Nrf2 repression in peripheral blood mononuclear 
cells of patients with stable coronary artery disease. Free 
Radic Biol Med 2014;68:178–185.
[15] Komura T, Sakai Y, Honda M, Takamura T, Matsushima K, 
Kaneko S. CD14  monocytes are vulnerable and functionally 
Figure 5. In vitro effects of PGPC on ROS generation and GRP78/BiP, CHOP, and Nrf2/ARE gene expression. Effect of PGPC concentration 
on ROS generation in THP-1 cells at 2 h and ON,  or 2 DPI (50 mM) and  SOD (150 U/ml)  CAT (200 U/ml) (a and b). mRNA and 
protein expression of PERK, CHOP, IkBa, Nrf2, and HO-1 after incubation with increasing amounts of PGPC (0.8–1.6 nmol/mL) (c and 
d). Representative Western blot analysis for the indicated proteins and the average quantification was obtained by densitometric analysis of 
all the samples. Data on Western blot analysis are expressed as the density ratio of target protein (1) to control (b-actin) (2) in arbitrary 
units. Data represent the mean  SD of measurements performed in triplicate in six different occasions. *p  0.01 versus basal, †p  0.01 
versus PGPC 0.8 nmol/mL basal, ‡p  0.01 versus PGPC  DPI, §p  0.01 versus PGPC 1.6 nmol/mL  DPI.
Fr
ee
 R
ad
ic
 R
es
 D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
U
ni
ve
rs
ita
 d
i V
er
on
a 
on
 0
2/
11
/1
5
Fo
r p
er
so
na
l u
se
 o
nl
y.
 Endoplasmic reticulum stress in diabetes  9
impaired under endoplasmic reticulum stress in patients with 
type 2 diabetes. Diabetes 2010;59:634–643.
[16] Fratta Pasini A, Anselmi M, Garbin U, Franchi E, Stranieri C, 
Nava MC, et al. Enhanced levels of oxidized low-density 
lipoprotein prime monocytes to cytokine overproduction via 
up-regulation of CD14 and toll-like receptor 4 in unstable 
angina. Arterioscler Thromb Vasc Biol 2007;27:1991–1997.
[17] Garbin U, Fratta Pasini A, Stranieri C, Cominacini M, 
Pasini A, Manfro S, et al. Cigarette smoking blocks the protec-
tive expression of Nrf2/ARE pathway in peripheral mononu-
clear cells of young heavy smokers favouring inflammation. 
PLoS One 2009;4:e8225.
[18] Watson AD, Leitinger N, Navab M, Faull KF, Hörkkö S, 
Witztum JL, et al. Structural identification by mass spectrom-
etry of oxidized phospholipids in minimally oxidized low den-
sity lipoprotein that induce monocyte/endothelial interactions 
and evidence for their presence in vivo. J Biol Chem 1997; 
272:13597–13607.
[19] Mao J, Zhang H, Luo J, Li L, Zhao R, Zhang R, Liu G. New 
method for HPLC separation and fluorescence detection of 
malonaldehyde in normal human plasma. J Chromatogr B 
Analyt Technol Biomed Life Sci 2006;17:832–838.
[20] Cominacini L, Fratta Pasini A, Garbin U, Davoli A, Tosetti ML, 
Campagnola M, et al. Oxidized low density lipoprotein (ox-
LDL) binding to ox-LDL receptor-1in endothelial cells induces 
the activation of NF-kappa B through an increased production 
of intracellular reactive oxygen species. J Biol Chem 2000; 
275:12633–12638.
[21] Robinson JP, Bruner LH, Bassoe CF, Hudson JL, Ward PA, 
Phan SH. Measurement of intracellular fluorescence of human 
monocytes relative of oxidative metabolism. J Leukoc Biol 
1988;43:304–310
[22] American Diabetes Association. Standard of medical care in 
Diabetes. Diabetes Care 2014, doi:10.2337/dc14-S014.
[23] Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, 
Biankin AV, Biden TJ. Endoplasmic reticulum stress contrib-
utes to b cell apoptosis in type 2 diabetes. Diabetologia 2007; 
50:752–763.
[24] Chang YC, Chuang LM. The role of oxidative stress in the 
pathogenesis of type 2 diabetes: from molecular mechanism 
to clinical implication. Am J Transl Res 2010;2:316–331.
[25] Karunakaran U, Park KG. A systemic review of oxidative 
stress and safety of antioxidants in diabetes: focus on islets 
and their defense. Diabetes Metab J 2013;37:106–112.
[26] Dierckx N, Horvath G, Van Gils C, Vertommen J, van de Vliet J, 
De Leeuw I, Manuel-y-Keenoy B. Oxidative stress status in 
patients with diabetes mellitus: relationship to diet. Eur J Clin 
Nutr 2003;57:999–1008.
[27] Del Rio D, Stewart AJ, Pellegrini N. A review of recent stud-
ies on malondialdehyde as a toxic molecule and biological 
marker of oxidative status. Nutr Metab Cardiovasc Dis 2005; 
15:316–328.
[28] Manohar SM, Vaikasuvu S, Deepthi K, Sachan A, Narasimha SR. 
An association of hyperglycemia with plasma malondialdehyde 
and atherogenic lipid risk factors in newly diagnosed Type 2 
diabetic patients. J Res Med Sci 2013;18:89–93.
[29] Rouhanizadeh M, Hwang J, Clempus RE, Marcu L, 
Lasse`gue B, Sevanian A, Hsiai TK. Oxidized-1-palmitoyl-2-
arachidonoyl-sn-glycero-3-phosphorylcholine induces vascu-
lar endothelial superoxide production: implication of NADPH 
oxidase. Free Radic Biol Med 2005;39:1512–1522.
[30] Tornatore L, Thatakura A, Benent J, Moretti M, Franzoso G. 
The nuclear factor kappa B signalling pathway: integrating 
metabolism and inflammation. Trends cell Biol 2012;22: 
557–566.
[31] Hotamisligil GS. Endoplasmic reticulum stress and the 
inflammatory basis of metabolic disease. Cell 2010;140: 
900–917.
[32] Kumar A, Takada Y, Boriek AM, Aggarwal BB. Nuclear 
Factor-kappaB: its role in health and disease. J Mol Med 
2004;82:434–448.
[33] Tam AB, Mercado EL, Hoffmann A, Niwa M. ER stress acti-
vates NF-kB by integrating functions of basal IKK activity, 
IRE1 and PERK. PLoS One 2012;7:e45078.
[34] Campo G, Avenoso A, Campo S, D’Ascola A, Traina P, 
Samà D, Calatroni A. NF-kB and caspases are involved in the 
hyaluronian and chondroitin-4-sulphate-exerted antioxidant 
effects in fibroblast cultures exposed to oxidative stress. J Appl 
Toxicol 2008;28:509–517.
[35] Kim H, Vaziri N. Contribution of impair Nrf2-Keap1 pathway 
to oxidative stress and inflammation in chronic renal failure. 
Am J Physiol Renal Physiol 2010;298:F662–F671.
[36] Suzuki M, Betsuyaku T, Ito Y, Nagai K, Nasuhara Y, Kaga K, 
et al. Down-regulated NF-E2-related factor 2 in pulmonary 
macrophages of aged smokers and patients with chronic 
obstructive pulmonary disease. Am J Respir Cell Mol Biol 
2008;39:673–682.
[37] Zhong Q, Mishra M, Kowluru RA. Transcription factor Nrf2-
mediated antioxidant defense system in the development of 
diabetic retinopathy. Invest Ophthalmol Vis Sci 2013;54: 
3941–3948.
[38] Monnier L, Mass K, Gainet C, Michel F, Villon L, Cristol JP. 
Activation of oxidative stress by acute glucose fluctuation 
compared with sustained chronic hyperglycemia in patients 
with type 2 diabetes. JAMA 2005;295:1681–1687.
[39] Monnier L, Colette C, Mas E, Michel F, Cristol JP, Boegner C, 
Owens D. Regulation of oxidative stress by glycaemic control: 
evidence for an independent inhibitory effect of insulin 
therapy. Diabetologia 2010;53:562–571.Fr
ee
 R
ad
ic
 R
es
 D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
U
ni
ve
rs
ita
 d
i V
er
on
a 
on
 0
2/
11
/1
5
Fo
r p
er
so
na
l u
se
 o
nl
y.
